The company has given 250 million reasons why investors should buy its stock.
Compare EBS Stock to Peers
|Symbol||Last Price||Market Cap||% Δ 1 Yr||% Δ 5 Yr|
News & Analysis: Emergent BioSolutions
The U.S. government canceled a contract related to pandemic preparation.
EBS earnings call for the period ending October 3, 2021.
EBS earnings call for the period ending June 30, 2021.
Yes, but it probably won't be an easy path.
The company went from hero to zero in the fight against COVID-19.
Shareholders beware: The hits just won't stop coming.
EBS earnings call for the period ending March 31, 2021.
The go-to government contractor is in deep trouble. Should investors buy the dip?